~~<i id='95198C7D55'><strike id='95198C7D55'><tt id='95198C7D55'><pre id='95198C7D55'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：Wikipedia 2025-09-29 09:43:05 Page View：9

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anthony Fauci pushes back on GOP claims during Covid hearing
Next article： Cancer drug shortages should be causing more outrage

comprehensive

Alkermes shareholders re

MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

STAT Readout Newsletter: Today's biggest biotech updates

Photoillustration:STATWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiot

DIEP, the 'gold standard' of breast reconstruction, is under threat

AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

How CO2 helps viruses stay alive longer in the air

AdobeCarbondioxidemonitorshavebeenaroundfordecades.Butin2020,theybecame,almostovernight,ahotcommodit